Envestnet Asset Management Inc Ultragenyx Pharmaceutical Inc. Transaction History
Envestnet Asset Management Inc
- $324 Billion
- Q3 2025
A detailed history of Envestnet Asset Management Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 25,033 shares of RARE stock, worth $832,347. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,033
Previous 29,956
16.43%
Holding current value
$832,347
Previous $1.09 Million
30.95%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding RARE
# of Institutions
363Shares Held
92.3MCall Options Held
3.46MPut Options Held
2.26M-
Vanguard Group Inc Valley Forge, PA10.1MShares$337 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$186 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY4.01MShares$133 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$131 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$96 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.33B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...